Regadenoson 0.08 mg / mL Injection 5 mL

Reference details for licensed healthcare facility review and verification.

Regadenoson NDC Family 16729-0477 Regadenoson 0.08 mg / mL

NDC 11	16729-0477-31
Product NDC	16729-0477
Generic Drug Name	Regadenoson
Brand Name	Regadenoson
Manufacturer	Accord Healthcare Inc.
Strength	0.08 mg / mL
Dosage Form	Injection
Drug Type	Intravenous
Package Quantity	5 mL
Package Description	5 mL in 1 SYRINGE, GLASS (16729-477-31)
Active Ingredients	Regadenoson
Marketing Category	ANDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this package-level listing or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

Regadenoson 0.08 mg / mL Injection is tracked under NDC 16729-0477-31 and rolls up into product family 16729-0477. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

Package configuration: 5 mL.
Manufacturer: Accord Healthcare Inc..
Dosage form: Injection.
Family size: 1 indexed presentation.

Click a tag to refine the catalog view around this product reference.

Review the generic familyRegadenoson

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Potential alternatives with matching presentation

Open the comparison hub or review package-level listings from 14 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.

View Potential Alternative HubRegadenoson Anhydrous 0.08 mg / mL Injection 5 mL Syringe14 package-level listings in the comparison hub.

Sample package-level pages in this comparison set

Regadenoson 0.08 mg / mL Injection 5 mLNDC 00409-1401-01 | 10 Carton | Hospira, Inc.Lexiscan - Regadenoson 0.08 mg / mL Injection 5 mLNDC 00469-6501-89 | 5 mL | Astellas Pharma US, Inc.Regadenoson 0.08 mg / mL Injection 5 mLNDC 00641-6253-01 | 1 Syringe, Plastic | Hikma Pharmaceuticals USA Inc.Regadenoson 0.08 mg / mL Injection 5 mLNDC 10135-0803-51 | 1 Syringe | Marlex Pharmaceuticals, Inc.Regadenoson 0.08 mg / mL Injection 5 mLNDC 36000-0364-01 | 1 Syringe, Plastic | Baxter Healthcare Corporation

Regadenoson 0.08 mg / mL Injection 5 mL, NDC 16729-0477-31, is a Accord Healthcare Inc. 0.08 mg / mL injection presentation packaged as 5 mL.

NDC search formats

Canonical NDC 11: 16729-0477-31
Digits-only NDC 11: 16729047731
Possible 10-digit display format: 16729-477-31 (1672947731)

Helpful product links

Search by brand name: Regadenoson
NDC 11: 16729-0477-31
Product family NDC: 16729-0477
VA classification code: CV900
VA classification code description: CARDIOVASCULAR AGENTS,OTHER
CMOP ID: R0240
VUID: 4027407